ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1933–1944 of 2020 project topics
Precision Medicine Biomarker Development from Genetics
Translating genetic discoveries into clinical biomarkers that can be measured to guide treatment selection and monitor therapy response.
Translational Genetics and Therapeutic Development Click to view more details →
Genetic Animal Model Development for Disease
Using genetic findings in human patients to guide development of relevant animal models that recapitulate human disease for therapeutic testing.
Translational Genetics and Therapeutic Development Click to view more details →
Pharmacogenomic Testing Platforms for Personalized Drug Dosing
Commercial laboratory platforms and SaaS dashboards that analyze patient genetic variants to predict optimal drug metabolism and dosing regimens before treatment initiation. These platforms generate recurring revenue through per-test fees, subscription licensing to healthcare systems, and integration partnerships with electronic health records.
Translational Genetics and Therapeutic Development Click to view more details →
Gene Therapy Manufacturing and Process Optimization Software
Specialized software solutions that optimize viral vector production, quality control, and scale-up protocols for commercial gene therapy manufacturing pipelines. These tools reduce production costs by 30-50% and accelerate time-to-market, creating licensing and service revenue streams for biotech companies and contract manufacturing organizations.
Translational Genetics and Therapeutic Development Click to view more details →
Genetic Variant Interpretation and Classification SaaS Platforms
Cloud-based platforms leveraging machine learning algorithms and curated databases to rapidly classify genetic variants as pathogenic, benign, or variants of uncertain significance for clinical reporting. These platforms monetize through subscription tiers, API access fees, and white-label solutions for diagnostic laboratories and healthcare providers.
Translational Genetics and Therapeutic Development Click to view more details →
Rare Disease Patient Registry and Matching Software Solutions
Proprietary patient registry platforms that aggregate genotypic and phenotypic data to identify undiagnosed patients and match them with clinical trials or targeted therapies. These solutions generate revenue through data licensing, clinical trial recruitment services, and real-world evidence contracts with pharmaceutical companies.
Translational Genetics and Therapeutic Development Click to view more details →
Polygenic Risk Score Development and Implementation Tools
Commercial platforms that construct, validate, and deploy polygenic risk scores across multiple populations for disease prediction and preventive medicine applications in primary care. These tools monetize through laboratory test offerings, clinical decision support licensing, and partnerships with insurance companies for risk stratification and preventive interventions.
Translational Genetics and Therapeutic Development Click to view more details →
Genetic Data Integration and Phenotype Mapping Enterprise Solutions
Enterprise software that integrates multi-omics genetic data with clinical phenotypes and electronic health records to enable large-scale genotype-phenotype association discovery. These platforms create value through data analytics consulting services, institutional licensing fees, and enabling pharma clients to discover novel genetic targets for drug development.
Translational Genetics and Therapeutic Development Click to view more details →
Intracranial Aneurysm Genetic Risk Studies
Conducting GWAS and family sequencing for identifying genetic variants predisposing to intracranial aneurysm formation and rupture.
Genetic Basis of Cerebrovascular Disease Click to view more details →
Moyamoya Disease RNF213 Variant Analysis
Characterizing RNF213 variants causing moyamoya disease particularly in East Asian populations for molecular risk assessment and family screening.
Genetic Basis of Cerebrovascular Disease Click to view more details →
CSVD Small Vessel Disease Genetics
Investigating common and rare genetic variants contributing to cerebral small vessel disease burden on brain imaging in population-based studies.
Genetic Basis of Cerebrovascular Disease Click to view more details →
Hereditary Hemorrhagic Stroke Genetics
Investigating familial intracerebral hemorrhage genetics including COL4A1, COL4A2, and other rare high-risk variants for cerebral hemorrhage.
Genetic Basis of Cerebrovascular Disease Click to view more details →